chrisvoncsefalvay/vaers-outcomes huggingface dataset:
I experience pain, redness, and swelling spanning several inches from an incorrectly administered Shingrix vaccination. I had warmth and redness of the skin and weakness.  I received it on 13 JAN 2023 from Immunization Clinic. Allergy Services, Department of Medicine Emailed Medical Center on 16 JAN 2023 2 16:25 subject: Shingrix Vaccine, of this reaction with a picture attached and did not receive a reply and/ or response due to his email distribution on 27 MAY 2022 subject: Safe Patient Care I also contacted Medical Center and emailed Medical Center Patient Advocate| Customer Relations, I received an email response from to call Customer Relations office by phone. I called and left a message and returned a follow-up email. There has not been any accountability or responsibility or reassurance the error has been or will be corrected.
Information has been received regarding a case in litigation from a lawyer regarding a patient of unknown age and gender. There was no information about patient's concomitant medications, concurrent conditions or pertinent medical history. On 05-JAN-2011, the patient was vaccinated with ZOSTAVAX (dose, route, anatomical location, lot number and expiration date were not reported) to obtain permanent prevention and protection against shingles and zoster-related injuries as recommended by the healthcare professional. On unknown date, the patient experienced shingles and in approximately 14-NOV-2011, the patient was treated for shingles. The patient was diagnosed with shingles and/or other zoster-related injuries after and despite being inoculated with the ZOSTAVAX and suffered serious physical, emotional, and economic damages, as a result of patient's injuries. The patient had and would continue suffer ongoing injuries, including but not limited to: mental and physical pain and suffered; extensive medical care and treatment for these injuries; significant medical and related expenses as a result of these injuries, including but not limited to medical losses and costs included care for hospitalization, physician care, monitoring, treatment, medications, and supplies; diminished capacity for the enjoyment of life; a diminished quality of life; increased risk of premature death, aggravation of preexisting conditions and activation of latent conditions; lost wages; loss of earnings capacity; and other losses and damages. At the time of the report, the patient was not recovered from emotional distress and pain, and the outcome of the patient regarding the vaccination failure, herpes zoster, quality of life decreased, and the pre-existing unspecified conditions aggravated was unknown. The reporter considered all aforementioned adverse events to be related to ZOSTAVAX. The reporter considered the events to be disabling, life-threatening and medically significant.
Sudden death w/no etiology @ autopsy; unclear as to whether it is related to vax;
Patient spoke with PCP on 4/20/12. She reported that she had a febrile reaction to Tdap along with chills and myalgias that lasted a few days. Pt has had boosters in the past without problems. ? relation to Pertussis component?
broke out w/rash around neck;11APR98 pt hit head & cried for 5min;p/crying pt fell, eyes rolled, teeth grit & loss of breathing, then shaking;911 called;pt mouth foamed;pt to ER;MD stated pt suffered sz w/temp;sz may be d/t vax;
Information has been received from a physician concerning an 18 yr old healthy female with no drug reactions/allergies who on 12Mar97, at the age of 10, was vaccinated with a dose of varicella virus vaccine live. It was noted that the pt had a negative titer for varicella. The anti complement immunoglourescent titer for varicella was negative. Unspecified medical attention was sought. There was no product quality complaint. Additional information has been requested.
This spontaneous report was received from a registered nurse refers to an unknown number of patients of unknown age and gender. Medical history, concurrent conditions and concomitant medications were not reported. On an unknown dates, the patient were inadvertently vaccinated with improperly stored VAQTA (strength, dose, frequency, and route of administration not reported). No adverse effects reported. No product quality complaint (PQC) was involved. No further information provided. This is one of several reports received from the same reporter. Additional information has been requested.
First the site had looked like a dark bruise, then the next day 01/10/2012, the site had started a small circle of redness that was warm to the touch and hurt when using the arm. The red area continued to grow each day the the pain of the site when the arm was used continued. Pt. thought it would go away but today it is an oval area about the width of a quarter's diameter and about twice as long over the lower tricept area on the Left arm. Pt was seen today with this report, 01/20/2012 @ 4:00 PM.
I HAD SWOLLEN LYMPH NODE IN RIGHT NECK UNDER JAWLINE AND NOT PAINFUL. IT WAS MOVABLE AND SOLID. HAD 2 ULTRASOUNDS OF THE NECK 1 MONTH A PART FROM EACH OTHER. APPEARED NONCANCEROUS. IT HAD GROWN IN SIZE. THE DOCTOR WOULD NOT BIOPSY IT AND SHE REFERRED ME TO RHUEMATOLOGY AND I'M WAITING FOR MY APPT NEXT MONTH.  I DON'T KNOW IF I HAD THE LYMPH NODE PRIOR TO THE VACCINE, I JUST NOTICED IT IN FEB AFTER MY 2ND SHOT.
This case was reported by a consumer and described the occurrence of double knee replacement in a female subject of unspecified age who was vaccinated with Lyme vaccine (GlaxoSmithKline). A physician or other health care professional has not verified this report. The subject had no history of joint problems before the vaccinations. On unspecified dates, the subject received 2 of the 3 doses of Lyme vaccine (unknown routes and injection sites, batch numbers not provided). At an unspecified time after vaccination with Lyme vaccine, the subject was forced to restrict her activities. She experienced joint problems and underwent double knee replacement. Her heartbeat was also irregular. This case was assessed as medically serious by GSK. At the time of reporting, the events were unresolved. The vaccination course with Lyme vaccine was discontinued since subject's physician advised her not to get the 3rd dose.
On Oct 14, 08 12:30 pm I received a flu shot in my (L) arm and pneumonia shot in my right arm. The needle hurt extremely bad and the medicine going into my (R) arm burned really bad also. I went home afterwards. At 5:00 pm right arm from shoulder all the way down began severely hurting. I could not move my arm at all and I would scream out with agonizing pain. Not able to move my arm and its 9:30 pm, agonizing pain still. I went to emergency room October 15, 2008. Doctors put my (R) arm in a sling and pain medicines. Oct 25 got better was able to take sling off arm.
6 days after the first dose he received a diagnostic with a positive test for COVID-19; 6 days after the first dose he received a diagnostic with a positive test for COVID-19; This is a spontaneous report from a non-contactable consumer (patient). A male patient of an unspecified age received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection; lot number and expiry date: not known), via an unspecified route of administration on 28Dec2020 at single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient called that he was administered with the first dose of Pfizer's COVID-19 vaccine on 28Dec2020 and 6 days after (03Jan2021) the first dose, he received a positive result for a COVID-19 laboratory test. He started with symptoms of COVID-19 between 4 to 6 days after the administration of the vaccine and he had scheduled the second dose of the vaccine in 2 days (at the time of report). He had been quarantined appropriately after being diagnosed. The outcome of the events was unknown.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Covid Arm - Redness at injection site 8 days after adnministration. Has decreased in size 2 days after initial appearance.  No Itching or Burning at injection site.
Second injection on a Friday.  Starting Sunday, 4/18, I have had waxing and waning hives - most pronounced at night but also periodically throughout the day.  I also had a swollen lip when I woke Tuesday morning, 4/20/21.  The swollen lip returned to normal after about two hours and has not returned.  I still have recurring hives that wax and wane throughout the day and at night.  I do not consider the hives to be a heavy rash.  They are itchy enough today that I took a Benadryl.  I would have taken one last night, but I had to drive 3 hours to a funeral today.     In addition, following the first vaccination (on 3/26/21), I had a swollen lip that night.    I did not consider attributing any of the foregoing symptoms to the vaccine until I read about symptoms at about 2 am this morning.  The fact sheet given to me when I got the vaccination really doesn't highlight the potential for a swollen lip or the onset of hives a couple days after the injection.  I did not have any immediate reaction to the injection (i.e., none during the 15 minute waiting period following either shot).
EXPIRE DOSE GIVEN; This spontaneous report received from a pharmacist concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 03-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 03-JUN-2021, the subject experienced expire dose given. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of expire dose given was not reported. This report was non-serious.
shingles left at T8, presenting with flank ache, + typical rash. Onset at 4.1.21, MOderna #1 given 3.10.21.
1.5 hours after I received the shot, sugar shot to 400.; This spontaneous case was reported by a consumer and describes the occurrence of BLOOD GLUCOSE INCREASED (1.5 hours after I received the shot, sugar shot to 400.) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027A21A) for an unknown indication.     The patient's past medical history included Stroke and Open heart surgery. Concomitant products included INSULIN and ACETYLSALICYLIC ACID, DIPYRIDAMOLE (AGGRENOX).    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On an unknown date, the patient experienced BLOOD GLUCOSE INCREASED (1.5 hours after I received the shot, sugar shot to 400.). At the time of the report, BLOOD GLUCOSE INCREASED (1.5 hours after I received the shot, sugar shot to 400.) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment medication include Took larger dose of Insulin. Other Concomitant medication include: on a lot of blood pressure medications, has diabetes, urinary bladder problems, and had strokes.; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded.
The patient received in February 1997 and April 1997 the first and second doses of varicella virus vaccine live. It was reported on 01/22/2001 that a recent titer showed negative antibodies. The patient sought unspecified medical attention. Additional information has been requested.
Site: Itching at Injection Site-Mild, Systemic: tingling-Mild, Systemic: Tingling (specify: facial area, extemities)-Mild
MOC states pt screamed from 8PM to 2AM on 12APR93; pt recvd the vax on 12APR93; had high pitched screaming which is not nl type of cry;
Clients mother stated shot record was up to date showing client needed 15 month shots. After given shots, more updated record found on computer. Client had recieved same vaccines 3-23-05. 6 months had not passed between #3 DTaP and one received on 3-23-05. #3 DTaP given 11-04-04. Client also received #4 Hib on 3-23-05.
patient received 2nd dose of vaccine.  patient came to pharmacy requesting RSV vaccine. Once the patient left pharmacy pharmacist saw history that first one was received 8/19/23, roughly 3 months prior. this is a one dose series. no side effects reported at this time.
Within an hour, I was experiencing flu-like symptoms. These symptoms were identical to those I experienced on my first injection shot that I did not report. Symptoms included: tiredness, muscle pain, headache , shivering, chills, dizziness, dehydration and nausea
Flu like symptoms not rash; This spontaneous case was reported by a consumer and describes the occurrence of INFLUENZA LIKE ILLNESS (Flu like symptoms not rash) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced INFLUENZA LIKE ILLNESS (Flu like symptoms not rash). At the time of the report, INFLUENZA LIKE ILLNESS (Flu like symptoms not rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) and mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitants were provided No treatment medications were provided.   Most recent FOLLOW-UP information incorporated above includes: On 09-Feb-2021: NNI On 22-Apr-2021: Significant follow up-event updated as flu like symptoms and not rash
Ringing in ears. Started out as being noticeable only at night and has progressed to being noticeable throughout the day, sometimes louder than others.
This spontaneous report was received from a consumer concerning her female friend of unknown age. On an unknown date, the patient was vaccinated with a dose of ZOSTAVAX (lot number, expiry date, dose and route unspecified). No concomitant medications were reported. On an unknown date, after receiving the vaccination, the patient experienced shingles. She sought medical attention (saw the health care professional) and she was treated with OXYCONTIN for pain. The outcome of the event was unknown. The relatedness for the event was unknown for ZOSTAVAX. Additional information is not expected.
Head / discomfort; dizzy; facial numbness; Sharp pain in head; Unusual headache / Vascular / in different places on her head / uncomfortable and annoying / Sharp pain in her head; Soreness and pain after receiving the vaccine at the injection site; annoying; uncomfortable; This case was reported by a nurse via call center representative and described the occurrence of vascular headache in a 76-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis.   On 11th June 2020, the patient received the 1st dose of Shingrix (intramuscular). On 12th June 2020, 1 days after receiving Shingrix, the patient experienced injection site pain. In June 2020, the patient experienced feeling irritated and discomfort. On 8th July 2020, the patient experienced dizziness, numbness facial and headache. In July 2020, the patient experienced vascular headache. On an unknown date, the patient experienced head discomfort. The patient was treated with paracetamol (Tylenol). On an unknown date, the outcome of the vascular headache, dizziness, numbness facial, injection site pain, head discomfort, feeling irritated, discomfort and headache were unknown.   It was unknown if the reporter considered the vascular headache, dizziness, numbness facial, injection site pain, head discomfort, feeling irritated, discomfort and headache to be related to Shingrix.  Additional case details were reported as follows: The patient received the 1st dose of Shingrix on 11th June 2020, and within the first week she developed an unusual headache on the outer side of her head that was vascular and she would get the headache in different places on her head and it would last all day and it was uncomfortable and annoying.  The Tylenol would help the headache some and massaging the area helped.  Two weeks ago, she was watching television and she experienced a sharp pain in her head and it left her dizzy and afterwards while she was sitting down she had facial numbness that would come and go and then the headache would start.  Three days ago, she has had some relief from the moving headache in her head but she still has the facial numbness. Things were currently improving overall. The numbness occurs on her forehead and it was earlier around her eyes. On 12th July 2020, the experienced soreness and pain after receiving the vaccine at the injection site that lasted close to a week and started. When she tilts her head, it makes the pain worse and rubbing the area and massaging the area also helps to ease the discomfort. She felt like the pain was on the outer edge of her head. She had an appointment with a neurologist.  The reporter consent to follow up.
Pt reports the next day post 2nd dose left arm sore, achy and pain with movement and sometimes hard to move (spasm in left arm). When she stays still there is no pain. Her entire body is achy still, pt reports "feeling broken". She reports her pain level is a 10. She also reports intermittent GI issues - cramps and nausea. Pt reports she had applied some bengay to help alleviate the pain which she reports it only helped for ~30 minutes to 1 hour. Pt reports she called her MD and was advised to contact us.
Next morning I could not look over right shoulder. Stiff painful neck. During the day gradually worsened to severe brachial neuritis pain from neck to shoulder blade to shoulder to armpit to entire arm. Worst pain to right of vertebrae at neck and upper back,  armpit, shoulder and elbow. By evening I was screaming.  Today it is now the eighteenth day. Worse every day and during the night. I scream in pain. I take Ibuprophen. Now I'm up to 600 mg every four hours. I did not have a GP. I found one. My first visit will be April 6. I am exhausted and afraid to take the second dose April 14. Note: When the person injected me, it was a hard jab with about half teaspoon of blood pouring down my arm. I am so out of my mind with this. I loved the fact that I was getting a vaccine. I was a healthy vibrant person, never sick, no medications,  never needing a doctor.  I fear my body is permanently changed now.
Itchy, red rash at injection site occurring 8 days after shot was given.    No biggie, but I figured you'd want to know.
TMG sore; Earache; Swelling in face; This spontaneous case was reported by a consumer and describes the occurrence of TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face). At the time of the report, TEMPOROMANDIBULAR JOINT SYNDROME (TMG sore), EAR PAIN (Earache) and SWELLING FACE (Swelling in face) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not reported.  Treatment information was not provided. .
My husband came home from a hunting trip, tested positive with COVID-19. I started watching and monitoring myself for COVID-19 symptoms. I started having a sore throat on November 25, 2022, I used a home COVID19 test that came back negative. On the November 26, 2022, my head started to hurt along with the sore throat, again I used a home COVID-19 test, it also came back negative. Later in the evening on November 27, 2022, I used a third home COVID-19 test, it came back positive. I called my doctors off and asked for the Paxlovid. I started taking the Paxlovid on the evening of November 28, 2022, by December 1, 2022, I went to the emergency room for tachycardia. They did an EKG, chest X-ray, found that I was in tachycardia. stopped my heart, reset it as this is something I have had to have done before. I was released after I was stable.
redness, bruising, swelling , pain and tenderness occurred on monday and began to improve on thursday. Using cold packs at injection  site.
CONFIRMED IMMUNOLOGICAL VACCINATION FAILURE; This spontaneous report received from a physician concerned a 60 year old female. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on 11-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested. Concomitant medications included prednisone.  On 2021, 6-8 weeks after covid-19 vaccination antibodies tests came up negative (coded to confirmed immunological vaccination failure). Laboratory data included: Antibody test (NR: not provided) negative. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of confirmed immunological vaccination failure was not reported. This report was serioQus (Other Medically Important Condition).; Sender's Comments: V0 : 20210506571- COVID-19 VACCINE AD26.COV2.S -Confirmed immunological vaccine failure. This event is considered not related. The event has a compatible/suggestive temporal relationship, is unlabeled, and has unknown scientific plausibility. There are other factors more likely to be associated with the event than the drug. Specifically: -OTHER SUSPECT DRUGS, SPECIAL SITUATIONS
Patient had a bruise at the site, she had a rash. It appears that the rash is already getting better. She has had the rash for just under a week. She is monitoring the rash and self treating with topical anti-itch medications.